Sphenopalatine Block Versus BOTOX in Management of Chronic Migraine

Clinical trial NCT06974617 · RECRUITING

Trial details

NCT number: NCT06974617
Sponsor: Cairo University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Sphenopalatine Block BOTOX Chronic Migraine

Start date: 2025-05-15
Primary completion: 2025-10-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.